Horm Metab Res 1997; 29(8): 373-378
DOI: 10.1055/s-2007-979058
Mini-Review

© Georg Thieme Verlag Stuttgart · New York

Corticotropin-Releasing Hormone-Binding Protein and its Possible Role in Neuroendocrinological Research

X.-J. Zhao1 , G. Hoheisel1 , J. Schauer1 , S. R. Bornstein2
  • 1Department of Internal Medicine I, Pneumology Unit, University of Leipzig, Germany
  • 2Department of Internal Medicine III, Endocrinology Unit, University of Leipzig, Germany
Further Information

Publication History

1997

1997

Publication Date:
23 April 2007 (online)

Corticotropin-releasing hormone-binding protein (CRH-BP), predominately produced by the liver, is a glycoprotein with a molecular weight of 37 kDa. The mature protein consists of 7 exons and 6 introns, with 5 tandem disulfide bridges which are essential for the binding of corticotropin-releasing hormone (CRH). This binding protein is distributed and expressed differently from corticotropin-releasing hormone receptors (CRH-Rs), as is the ligand requirement. Most CRH in plasma is bound to its binding protein, is therefore inactive and unable to bind to its receptor. Other competitives can reverse the binding, liberating CRH. Together with the CRH neuropeptides and CRH receptors, CRH-binding protein plays a role in the hypothalamic-pituitary-adrenal axis, in immune/inflammatory reactions as an auto/paracrine proinflammatory regulator, in pregnancy, as well as in some pathological conditions.